CNS Pharmaceuticals (CNSP) EBIT (QoQ) (2018 - 2025)
CNS Pharmaceuticals (CNSP) EBIT (QoQ) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - |
| 10 | CNS Pharmaceuticals | 2.68 Mn | -4.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -84.00% |
| Sep 30, 2025 | -35.03% |
| Jun 30, 2025 | 44.45% |
| Mar 31, 2025 | -35.55% |
| Dec 31, 2024 | 43.15% |
| Sep 30, 2024 | -122.65% |
| Jun 30, 2024 | 28.68% |
| Mar 31, 2024 | 34.10% |
| Dec 31, 2023 | -18.65% |
| Sep 30, 2023 | -12.63% |
| Jun 30, 2023 | 18.29% |
| Mar 31, 2023 | 4.05% |
| Dec 31, 2022 | -50.18% |
| Sep 30, 2022 | 4.08% |
| Jun 30, 2022 | -13.18% |
| Mar 31, 2022 | 3.15% |
| Dec 31, 2021 | 14.73% |
| Sep 30, 2021 | -0.05% |
| Jun 30, 2021 | -5.59% |
| Mar 31, 2021 | -20.26% |